Auto-generated from public data. Not the firm's stated position.
Based on disclosed data, The Case for Her appears to focus on early-stage women's health and reproductive technology companies in Europe, with recent portfolio activity concentrated in digital health applications and e-commerce platforms serving female-specific health needs. The firm's check size range and stage focus suggest an investment thesis centered on pre-seed and seed-stage healthtech ventures addressing underserved segments within women's wellness and healthcare.
Generated 14 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Auto-detected from The Case for Her's website.
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.